CVS Health (CVS) Now Covered by Analysts at Deutsche Bank

Research analysts at Deutsche Bank began coverage on shares of CVS Health (NYSE:CVS) in a report issued on Monday. The brokerage set a “buy” rating on the pharmacy operator’s stock.

Other equities analysts also recently issued reports about the stock. Citigroup lowered their target price on shares of CVS Health from $88.00 to $87.00 and set a “neutral” rating on the stock in a report on Thursday, August 17th. Royal Bank Of Canada assumed coverage on shares of CVS Health in a report on Tuesday, September 19th. They set an “outperform” rating and a $95.00 target price on the stock. Jefferies Group boosted their target price on shares of CVS Health from $82.00 to $86.00 and gave the stock a “hold” rating in a report on Friday, September 15th. Wolfe Research downgraded shares of CVS Health from an “outperform” rating to a “market perform” rating and lowered their target price for the stock from $89.00 to $82.00 in a report on Monday, August 14th. Finally, Mizuho set a $90.00 target price on shares of CVS Health and gave the stock a “buy” rating in a report on Tuesday, October 24th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and fifteen have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $85.82.

Shares of CVS Health (NYSE CVS) opened at $75.12 on Monday. The company has a quick ratio of 0.55, a current ratio of 1.05 and a debt-to-equity ratio of 0.67. The company has a market cap of $76,095.96, a price-to-earnings ratio of 13.16, a PEG ratio of 1.29 and a beta of 0.89. CVS Health has a 1 year low of $66.45 and a 1 year high of $84.72.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.01. The business had revenue of $46.18 billion for the quarter, compared to analyst estimates of $46.17 billion. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The firm’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.64 earnings per share. research analysts forecast that CVS Health will post 5.9 EPS for the current year.

In other CVS Health news, EVP Thomas M. Moriarty sold 90,267 shares of the company’s stock in a transaction on Monday, September 11th. The shares were sold at an average price of $79.61, for a total value of $7,186,155.87. Following the transaction, the executive vice president now directly owns 70,102 shares in the company, valued at $5,580,820.22. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Larry J. Merlo sold 241,150 shares of the company’s stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $83.07, for a total transaction of $20,032,330.50. Following the completion of the transaction, the insider now owns 299,255 shares in the company, valued at $24,859,112.85. The disclosure for this sale can be found here. Over the last quarter, insiders sold 714,125 shares of company stock worth $58,119,381. Corporate insiders own 0.61% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the stock. Horan Capital Advisors LLC. grew its stake in shares of CVS Health by 3.2% in the second quarter. Horan Capital Advisors LLC. now owns 32,115 shares of the pharmacy operator’s stock valued at $2,584,000 after acquiring an additional 1,000 shares in the last quarter. Community Bank N.A. grew its stake in shares of CVS Health by 7.3% in the second quarter. Community Bank N.A. now owns 19,976 shares of the pharmacy operator’s stock valued at $1,608,000 after acquiring an additional 1,362 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its position in CVS Health by 3.2% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 176,294 shares of the pharmacy operator’s stock worth $13,840,000 after purchasing an additional 5,478 shares during the period. Midwest Investment Management LLC lifted its position in CVS Health by 6.2% during the second quarter. Midwest Investment Management LLC now owns 21,382 shares of the pharmacy operator’s stock worth $1,720,000 after purchasing an additional 1,245 shares during the period. Finally, Fiduciary Trust Co. lifted its position in CVS Health by 1.2% during the first quarter. Fiduciary Trust Co. now owns 366,007 shares of the pharmacy operator’s stock worth $28,732,000 after purchasing an additional 4,265 shares during the period. Institutional investors and hedge funds own 82.24% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “CVS Health (CVS) Now Covered by Analysts at Deutsche Bank” was first posted by Community Financial News and is owned by of Community Financial News. If you are reading this report on another site, it was stolen and reposted in violation of US & international copyright law. The legal version of this report can be accessed at https://www.com-unik.info/2017/12/04/cvs-health-cvs-now-covered-by-analysts-at-deutsche-bank.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Analyst Recommendations for CVS Health (NYSE:CVS)

What are top analysts saying about CVS Health Corp? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CVS Health Corp and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit